Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center - 30/01/13
Doi : 10.1016/j.jaci.2012.08.022
Thierry Ducruet, MSc a, Marie-Claude Levasseur, RN, BSc b, Anne Des Roches, MD b, Ayman Kafal, PhD c, Renée Dicaire, RN b, Elie Haddad, MD, PhD b, d 
a Unité de recherche clinique appliquée (URCA), University of Montreal, Centre de Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada
b Department of Pediatrics, University of Montreal, Centre de Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada
c CSL Behring, Ottawa, Ontario, Canada
d Department of Microbiology and Immunology, University of Montreal, Centre de Recherche, CHU Sainte-Justine, Montreal, Quebec, Canada
| Supported by an investigator-initiated trial grant from CSL-Behring (E.H.). E.H. is a scholar of the Fonds de Recherche en Santé du Québec. |
|
| Disclosure of potential conflict of interest: T. Ducruet has received a consulting honorarium from Ste-Justine Hospital. M.-C. Levasseur has received consultancy fees from CSL Behring. E. Haddad has received research support and consultancy fees from CSL Behring. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2012
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 131 - N° 2
P. 585 - février 2013 Retour au numéro
Article précédent
- TGF-β1 polymorphisms and asthma severity, airway inflammation, and remodeling
- Despo Ierodiakonou, Dirkje S. Postma, Gerard H. Koppelman, Jorrit Gerritsen, Nick H.T. ten Hacken, Wim Timens, H. Marike Boezen, Judith M. Vonk
- Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
- Masaki Shimizu, Hirokazu Kanegane, Taizo Wada, Yaeko Motoyoshi, Tomohiro Morio, Fabio Candotti, Akihiro Yachie
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?